This bill amends the Federal Food, Drug, and Cosmetic Act to declare a group of commonly used color additives unsafe for use in or on food and to treat any food that is, bears, or contains those additives as adulterated. The list includes the major synthetic dyes used in many processed foods and confectionery — and expressly adds titanium dioxide plus a catch‑all for additives substantially similar to those listed.
That change is effective beginning January 1, 2027. The shift would convert currently permitted, certified, or exempted color additives into barred ingredients for foods, creating immediate compliance, reformulation, importation, and enforcement implications for manufacturers, ingredient suppliers, retailers, and federal regulators.
At a Glance
What It Does
The bill overrides existing FD&C Act certification and listing regimes by using the adulteration standard to prohibit covered color additives from food. It does not create new labeling rules or a separate enforcement mechanism; instead, it places enforcement onto the FDA’s existing adulteration authority and the remedies that flow from section 402(c).
Who It Affects
Food and beverage manufacturers, ingredient suppliers (especially pigment producers), importers and distributors of processed foods and confections, and the FDA (which will handle enforcement and detention). Food service firms and retailers that sell products already on shelves will also face immediate compliance choices.
Why It Matters
By converting permitted additives into adulterants by statute, the bill short-circuits the usual scientific review and certification process and triggers recalls, detentions, and potential seizures under current law. That creates large operational and legal adjustments around reformulation, testing, and cross-border trade.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill uses the Federal Food, Drug, and Cosmetic Act’s existing adulteration framework rather than creating a parallel regulatory path. Rather than asking FDA to revoke approvals through the agency rulemaking or re-review processes, Congress would statutorily declare certain color additives unsafe for food and call foods containing them adulterated.
That legal framing makes enforcement immediate under the tools already in FDA’s toolbox: detention of imports, inspections, warning letters, voluntary or mandatory recalls, and criminal or civil actions where applicable.
Because the statute treats any food that “is, or it bears or contains” the covered additives as adulterated, the practical reach is broad: manufacturers that add pigments intentionally, co-packers working on multiple recipes, and finished-goods importers face exposure even if the pigment is present only in surface coatings, printing inks on edible wrappers, or as trace carryover. The bill does not carve out exemptions for small producers, traditional foods, or food-contact adhesives; it also does not specify a tolerance threshold or de minimis level, so trace contamination becomes a compliance risk.Operationally, affected companies will need to choose between reformulating to permitted colorants (natural or synthetic alternatives), redesigning product presentations that avoid added dyes, or exiting product lines.
Ingredient suppliers of synthetic dyes will see lost food market access and will need to redirect sales to nonfood uses or pursue regulatory or litigation strategies. Regulators will have to set enforcement priorities, sampling and testing protocols, and guidance on how to treat legacy inventory — decisions the bill leaves to existing FDA procedures rather than to new statutory detail.
The Five Things You Need to Know
The bill uses the phrase “notwithstanding the listing and certification (or exemption…) pursuant to section 721” to override existing color additive certifications.
It deems any covered color additive “unsafe for use in or on food within the meaning of subsection (a)” of section 721, converting legal status rather than prescribing a new technical standard.
The statute declares foods that “are, or it bears or contains” the specified additives to be adulterated under section 402(c) of the FD&C Act.
The definition of covered color additives includes titanium dioxide and ends with a broad catch‑all for any additive “substantially similar” to the listed substances.
The effective date in the bill sets a statutory compliance trigger that begins enforcement actions under existing FDA authority on January 1, 2027.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s name, a procedural element that has no operational effect but signals legislative intent. Short titles matter in litigation and policy discussions because courts and agencies often cite them when parsing legislative purpose.
Deeming covered additives unsafe and foods adulterated
Imposes the substantive change: regardless of any existing FDA listing, certification, or exemption, the named additives are statutorily treated as unsafe and foods containing them are adulterated. Practically, this funnels enforcement into section 402(c)'s remedies — detentions, refusals of admission for imports, administrative or judicial actions — without creating new regulatory tests or tolerances.
Defines 'covered color additive' and creates a broad catch‑all
Lists ten specific color additives by common name and CAS number and then adds any additive ‘substantially similar’ to those. The CAS numbers anchor the statute to chemical identities, but the catch‑all introduces interpretive questions about structural, functional, or toxicological similarity that courts and FDA will need to resolve.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Parents and pediatric health advocates — elimination of certain synthetic dyes from food marketed to children reduces exposure pathways that many studies have flagged as behavioral or developmental concerns.
- Manufacturers of natural colorants and alternative ingredients — companies producing beet, turmeric, annatto, or other natural pigments will gain market opportunities as food formulators seek substitutes.
- Public interest and consumer health organizations — a statutory ban simplifies advocacy and reduces the need for protracted administrative petitions to change FDA policy.
Who Bears the Cost
- Packaged food and beverage manufacturers (especially confectionery, snacks, and beverages) — face reformulation costs, product redevelopment, supply‑chain disruption, and potential lost sales for reformulated products.
- Ingredient suppliers of synthetic dyes and distributors — will lose food business lines and may incur inventory write-downs or need to redirect sales to nonfood markets.
- Importers and small-scale producers — may encounter detention of goods at the border or need rapid adjustments without scale economies, raising compliance costs and the risk of wasted inventory.
- FDA and Customs and Border Protection — will shoulder implementation work (testing protocols, guidance, enforcement prioritization) without any funding in the bill, potentially stretching inspection resources.
Key Issues
The Core Tension
The central tension is between the desire for immediate, protective action on food additives and the costs of a blunt statutory ban: the bill accelerates public‑health protections by statute, but it does so without the technical definitions, thresholds, or implementation funding that would make enforcement predictable and equitable.
The bill resolves one regulatory hurdle by bypassing FDA re-review, but leaves a number of implementation details unresolved. It does not define “substantially similar,” set analytic thresholds for enforcement, or provide safe-harbor levels for unavoidable trace contamination.
That ambiguity will force FDA and potentially the courts to interpret the catch‑all and the scope phrases, creating litigation and uneven enforcement across jurisdictions. The statute also does not fund new testing capacity or provide guidance on handling existing inventory, so practical enforcement will depend on FDA policy choices and resource allocation.
Internationally and for trade, the bill creates potential mismatches with Codex standards and trading partners that still allow some of these additives. Import detention and refusals could increase, prompting disputes and supply-chain rerouting.
Finally, by treating additives as adulterants rather than setting a new scientific standard, the law substitutes congressional policy for agency fact-finding — efficient for rapid change but more vulnerable to legal challenge on administrative or preemption grounds, and it forecloses incremental regulatory options such as labeling, restrictions by food class, or concentration limits.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.